🔎 Trials Near Me

Home › Atherosclerosis › Pennsylvania

Atherosclerosis clinical trials in Pennsylvania

9 studies for Atherosclerosis are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • Capital Area Research, LLC - Camp Hill, Camp Hill
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 5, 2026 · NCT07521007

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

  • Heart and Vascular Research at WellSpan Health, York
RecruitingPhase 3
Ages 45 to 80 · All sexes · Updated Nov 4, 2026 · NCT07613294

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Suburban Research Associates, West Chester
  • Cardiology Consultants of Philadelphia Yardley, Yardley
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802

How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses

  • UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
RecruitingHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 6, 2026 · NCT07121010

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Lehigh Valley Health Network, Allentown
  • Capital Area Research, LLC, Camp Hill
  • Altoona Center For Clinical Research, Duncansville
  • and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Northeast Clinical Research Center, LLC, Bethlehem
  • Clinical Renal Associates, LTD, Exton
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Camp Hill
  • Research Site, Horsham
  • Research Site, Philadelphia
  • and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RecruitingPhase 3
Ages 35 to 89 · All sexes · Updated Apr 21, 2026 · NCT05132439

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.